** = Publications listed in SCI/SSCI/Pubmed
** Amrein, K; Dobnig, H; Wagner, D; Piswanger-Sölkner, C; Pieber, TR; Pilz, S; Tomaschitz, A; Dimai, HP; Fahrleitner-Pammer, A
Sclerostin in institutionalized elderly women: associations with quantitative bone ultrasound, bone turnover, fractures, and mortality.
J Am Geriatr Soc. 2014; 62(6):1023-1029
Doi: 10.1111/jgs.12791
Web of Science
PubMed
FullText
FullText_MUG
** Pilz, S; Meinitzer, A; Tomaschitz, A; Kienreich, K; Dobnig, H; Schwarz, M; Wagner, D; Drechsler, C; Piswanger-Sölkner, C; März, W; Fahrleitner-Pammer, A
Associations of homoarginine with bone metabolism and density, muscle strength and mortality: cross-sectional and prospective data from 506 female nursing home patients.
Osteoporos Int. 2013; 24(1):377-381
Doi: 10.1007/s00198-012-1950-9
Web of Science
PubMed
FullText
FullText_MUG
** Friedl, C; Sampl, E; Prandl, EC; Wagner, D; Piswanger-Soelkner, JC; Rosenkranz, AR; Fahrleitner-Pammer, A
Osteoporosis, weight gain and atypical fat accumulations - a typical feature not only for Cushing's, but also Madelung's disease: A case report.
Wien Klin Wochenschr. 2012; 124(5-6):188-192
Doi: 10.1007/s00508-011-0045-5
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Pilz, S; Dobnig, H; Tomaschitz, A; Kienreich, K; Meinitzer, A; Friedl, C; Wagner, D; Piswanger-Sölkner, C; März, W; Fahrleitner-Pammer, A
Low 25-hydroxyvitamin D is associated with increased mortality in female nursing home residents.
J Clin Endocrinol Metab. 2012; 97(4): E653-E657.
Doi: 10.1210/jc.2011-3043
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wagner, D; Dobnig, H; Tscheliessnigg, K; Prenner, G; Wasler, A; Piswagner-Solkner, C; Kniepeiss, D; Fahrleinter, A
TESTOSTERONE REPLACEMENT IN CARDIAC TRANSPLANT PATIENTS ON TOP OF BISPHOSPHONATE THERAPY EXERTS MULTIPLE BENEFITS ON BONE MASS, LIBIDO AND SEXUAL ACTIVITY
TRANSPL INT. 2011; 24: 332-332.
[Oral Communication]
Web of Science
** Wagner, D; Dobnig, H; Iberer, F; Prenner, G; Kniepeiss, D; Leb, G; Tscheliessnig, KH; Piswanger, C; Fahrleitner, A
Combination Therapy with Ibandronate and Calcitrol Is Efffective in Patients Following Liver Transplantation (LTX): A Three Year Prospective Controlled Study
LIVER TRANSPLANT. 2010; 16(6):S248-S248.
[Poster]
Web of Science
** Fahrleitner-Pammer, A; Piswanger-Soelkner, JC; Pieber, TR; Obermayer-Pietsch, BM; Pilz, S; Dimai, HP; Prenner, G; Tscheliessnigg, KH; Hauge, E; Portugaller, RH; Dobnig, H
Ibandronate prevents bone loss and reduces vertebral fracture risk in male cardiac transplant patients: a randomized double-blind, placebo-controlled trial.
J Bone Miner Res. 2009; 24(7): 1335-1344.
Doi: 10.1359/jbmr.090216
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Fahrleitner-Pammer, A; Piswanger-Soelkner, JC; Obermayer-Pietsch, BM; Friedl, C; Prenner, G; Tscheliessnigg, K; Dobnig, H
Testosterone replacement in combination with bisphosphonate therapy in male cardiac transplant patients exerts additional benefits on bone mass: A 5-year prospective study
BONE. 2009; 44(2):S424-S424.-ECTS; June 2009; Vienna; Austria.
Doi: 10.1016/j.bone.2009.03.362
[Poster]
Web of Science
FullText
FullText_MUG
** Lipp, RW; Schnedl, WJ; Bock, G; Kohler, G; Horvath, K; Mader, JK; Pieber, TR; Piswanger-Soelkner, J
Gastric emptying as prognostic factor for life expectancy in patients with type 1 diabetes
DIABETOLOGIA. 2009; 52: 977--45th Annual Meeting of the EASD (European Association for the Study of Diabetes); SEP 29 - OCT 2, 2009; Vienna, AUSTRIA.
[Poster]
Web of Science
** Piswanger-Soelkner, J; Schnedl, WJ; Bock, G; Kohler, G; Horvath, K; Mader, JK; Pieber, TR; Lipp, RW
The influence of gastric emptying patterns on blood glucose in type 1 diabetes
DIABETOLOGIA. 2009; 52: 978--45th Annual Meeting of the EASD (European Association for the Study of Diabetes); SEP 29 - OCT 2, 2009; Vienna, AUSTRIA.
[Poster]
Web of Science
** Piswanger-Solkner, JC; Schnedl, W; Bock, G; Kohler, G; Pieber, T; Lipp, R
Type of Gastric emptying and Behavior and Glucose levels in Type 1 Diabetics.
WIEN KLIN WOCHENSCHR. 2009; 121: S21-S21.-37. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 19-21, 2009; Salzburg, Österreich.
[Oral Communication]
Web of Science
** Fahrleitner-Pammer, A; Obermayer-Pietsch, B; Schweiger, M; Prenner, G; Tscheliessnigg, K.H; Piswanger-Sölkner, J.C; Dimai, H.P; Dobnig, H.
Replacing testosterone in male cardiac transplant patients exerts multiple benefits on bone mass, libido and sexual activity: A 5-year prospective study.
. 2008; 23: S471
[Poster]
Web of Science
** Dobnig, H; Piswanger-Sölkner, JC; Obermayer-Pietsch, B; Tiran, A; Strele, A; Maier, E; Maritschnegg, P; Riedmüller, G; Brueck, C; Fahrleitner-Pammer, A
Hip and nonvertebral fracture prediction in nursing home patients: role of bone ultrasound and bone marker measurements.
J Clin Endocrinol Metab. 2007; 92(5): 1678-1686.
Doi: 10.1210/jc.2006-2079
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Gnant, MF; Mlineritsch, B; Luschin-Ebengreuth, G; Grampp, S; Kaessmann, H; Schmid, M; Menzel, C; Piswanger-Soelkner, JC; Galid, A; Mittlboeck, M; Hausmaninger, H; Jakesz, R; Austrian Breast and Colorectal Cancer Study Group
Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group.
J Clin Oncol. 2007; 25(7): 820-828.
Doi: 10.1200/JCO.2005.02.7102
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schnedl, WJ; Lahousen, T; Krause, R; Wallner, SJ; Piswanger-Soelkner, C; Lipp, RW
Evaluation of conditions associated with glycated hemoglobin values below the reference range.
Clin Lab. 2007; 53(3-4):179-181
Web of Science
PubMed
** Dunzinger, A; Gary, T; Piswanger-Soelkner, JC; Brodmann, M; Lipp, RW
Detection of acute deep vein thrombosis in symptomatic patients with Tc99m-apcitide
EUR J NUCL MED MOL IMAGING. 2007; 34: S140-S140.-Annual Congress of the EANM 2007; OCT 13-17,2007; Copenhagen.
[Poster]
Web of Science
** Dobnig, H; Piswanger-Sölkner, JC; Roth, M; Obermayer-Pietsch, B; Tiran, A; Strele, A; Maier, E; Maritschnegg, P; Sieberer, C; Fahrleitner-Pammer, A
Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass, and fracture risk.
J Clin Endocrinol Metab. 2006; 91(9):3355-3363
Doi: 10.1210/jc.2006-0460
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Krause, R; Piswanger-Soelkner, C; Lipp, RW; Daxböck, F; Schnedl, WJ; Hoier, S; Reisinger, EC
Somatostatin receptor scintigraphy in patients with cat-scratch disease.
Nuklearmedizin. 2006; 45(4):160-162
Doi: 10.1055/s-0038-1625110
Web of Science
PubMed
FullText
FullText_MUG
** Peintinger, F; Georgoulopoulos, A; Ralph, G; Piswanger, C
Retrospective comparison of chemotherapy-induced myelotoxicity in patients with ovarian cancer under and over 60 years of age.
J Chemother. 2006; 18(6): 656-661.
Doi: 10.1179/joc.2006.18.6.656
Web of Science
PubMed
FullText
FullText_MUG
** Schnedl, WJ; Pilhatsch, A; Szolar, DH; Krause, R; Wallner, SJ; Piswanger, C; Lipp, RW
Intestinal malrotation and delayed gastric emptying.
Nuklearmedizin. 2005; 44(5):N46-N48
(- Case Report)
Web of Science
PubMed
** Schnedl, WJ; Wallner, SJ; Piswanger, C; Krause, R; Lipp, RW
Glycated hemoglobin and liver disease in diabetes mellitus.
Wien Med Wochenschr. 2005; 155(17-18):411-415
Doi: 10.1007/s10354-005-0210-4
PubMed
FullText
FullText_MUG
** Dimai, HP; Fahrleitner, A; Piswanger-Soelkner, C; Ramschak-Schwarzer, S; Obermayer-Pietsch, B; Leb, G
A new hormonal upstream factor in the RANKL/OPG system? Effects of the thyroid stimulating hormone TSH in humans
J BONE MINER RES 2004 19: S414-S414.
Web of Science
** Dimai, HP; Piswanger-Soelkner, C; Fahrleitner, A; Ramschak-Schwarzer, S; Wenisch, H; Gugatschka, M; Obermayer-Pietsch, B; Leb, G
Another hormonal upstream factor in the OPG/RANKL system? Effects of the thyroid stimulating hormone TSH on bone metabolism
OSTEOPOROSIS INT 2004 15: S16-S17.
Web of Science
** Fahrleitner-Pammer, A; Prenner, G; Kniepeiss, D; Tschelissnigg, K; Leb, G; Piswanger-Solkner, CJ; Obermayer-Pietsch, BM; Dobnig, H
Combination therapy with ibandronate and calcitriol is effective in patients following liver transplantation: A three year prospective controlled study.
J BONE MINER RES 2004 19: S475-S475.
Web of Science
** Roth, M; Fahrleitner, A; Piswanger-Solkner, CJ; Obermayer-Pietsch, B; Tiran, A; Leb, G; Maier, E; Dobnig, H
Institutionalized elderly type II diabetics have higher bone mass, lower bone turnover markers and PTH levels compared to non-diabetics: Evidence for decreased calcium sensing by parathyroid glands.
J BONE MINER RES 2004 19: S439-S439.
Web of Science
** Fahrleitner, A; Prenner, G; Leb, G; Tscheliessnigg, KH; Piswanger-Sölkner, C; Obermayer-Pietsch, B; Portugaller, HR; Berghold, A; Dobnig, H
Serum osteoprotegerin is a major determinant of bone density development and prevalent vertebral fracture status following cardiac transplantation.
Bone. 2003; 32(1):96-106
Doi: 10.1016%2FS8756-3282%2802%2900926-2
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Fahrleitner-Pammer, A; Dobnig, H; Piswanger-Soelkner, C; Bonelli, C; Dimai, HP; Leb, G; Obermayer-Pietsch, B
Osteoprotegerin serum levels in women: correlation with age, bone mass, bone turnover and fracture status.
Wien Klin Wochenschr. 2003; 115(9):291-297
Doi: 10.1007/BF03040334
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Dimai, HP; Piswanger-Soelkner, C; Fahrleitner, A; Ramschak-Schwarzer, S; Wenisch, H; Gugatschka, M; Leb, G
Is bone metabolism affected by the human thyroid stimulating hormone TSH? Preliminary results from a clinical study in patients with TSH-suppressive thyroid hormone therapy
BONE 2003 33: S13-S13.
Web of Science
** Roth, M; Fahrleitner, A; Piswanger-Solkner, C; Obermayer-Pietsch, B; Leb, G; Dobnig, H
Diabetes mellitus in institutionalized patients is associated with higher bone mass measured by ultrasonography as well as lower iPTH levels and markers of bone turnover
BONE 2003 33: S14-S14.
Web of Science
** Fahrleitner, A; Prenner, G; Kniepeiss, D; Iberer, F; Tscheliessnigg, KH; Piswanger-Sölkner, C; Obermayer-Pietsch, B; Leb, G; Dobnig, H
Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status.
Wien Klin Wochenschr. 2002; 114(15-16):717-724
Web of Science
PubMed
Google Scholar
** Bonelli, CM; Walter, D; Fahrleitner, A; Piswanger-Solkner, CJ; Dobnig, H; Linhart, W; Reitinger, T; Windhager, R; Leb, G; Obermayer-Pietsch, BM
Congenital hip dysplasia and disturbances of bone and connective tissue in adult female patients
OSTEOPOROSIS INT 2002 13: S61-S61.
Web of Science
** Fahrleitner, A; Dobnig, H; Leb, G; Dimai, HP; Piswanger-Solkner, C; Bonelli, CM; Obermayer-Pietsch, B
Osteoprotegerin serum levels in women: Influence of age, bone mass, bone turnover and fracture status
OSTEOPOROSIS INT 2002 13: S52-S52.
Web of Science
** Fahrleitner, A; Prenner, G; Tscheliessnigg, KH; Leb, G; Piswanger-Solkner, CJ; Obermayer-Pietsch, B; Dimai, HP; Dobnig, H
Testosterone supplementation has additional benefits on bone metabolism in cardiac transplant recipients receiving intravenous bisphosphonate treatment: A prospective study.
J BONE MINER RES 2002 17: SU423-SU423.
Web of Science
** Obermayer-Pietsch, BM; Li, W; Fahrleitner, A; Piswanger-Solkner, CJ; Bonelli, CM; Leb, G; Dobnig, H
Polymorphisms of the vitamin D receptor and the collagen I alpha 1 genes as genetic risk factors for bone fractures in a high risk population in Austrian nursing homes
OSTEOPOROSIS INT 2002 13: S64-S64.
Web of Science
** Bonelli, CM; Fahrleitner, A; Walter, D; Stepan, V; Piswanger-Solkner, CJ; Dobnig, H; Leb, G; Obermayer-Pietsch, B
Osteoporosis and bone metabolism in premenopausal patients with congenital hip dysplasia
BONE 2001 28: S191-S191.
Web of Science
** Dobnig, H; Fahrleitner, A; Prenner, G; Tscheliessnig, KH; Piswanger-Solkner, C; Leb, G
Serum osteoprotegerin is a major determinant of bone density and vertebral fracture status in patients after cardiac transplantation
BONE 2001 28: S97-S97.
Web of Science
** Fahrleitner, A; Prenner, G; Kniepeiss, D; Tscheliessnigg, KH; Stach, L; Piswanger-Solkner, C; Leb, G; Dobnig, H
Evidence for continued bone loss after cardiac transplantation - A cross sectional study in 53 patients
OSTEOPOROSIS INT 2000 11: 379-379.
Web of Science